research
Some Teen Patients Restarted GLP-1s After Surgery
A 99-patient retrospective cohort associated restarting medication within three months with greater one-year weight loss.
Summary
A 99-patient retrospective cohort associated restarting medication within three months with greater one-year weight loss.
Children's Hospital Los Angeles compared 53 young patients who chose to resume a GLP-1 drug after sleeve gastrectomy with 46 who did not. Weight and eating outcomes favored the restart group without a detected safety difference, but self-selection limits causal claims; a randomized trial is planned.
Why it matters
A 99-patient retrospective cohort associated restarting medication within three months with greater one-year weight loss.
Limits and context
- Children's Hospital Los Angeles compared 53 young patients who chose to resume a GLP-1 drug after sleeve gastrectomy with 46 who did not.
Key claims
A 99-patient retrospective cohort associated restarting medication within three months with greater one-year weight loss.
Qualification: Children's Hospital Los Angeles compared 53 young patients who chose to resume a GLP-1 drug after sleeve gastrectomy with 46 who did not.
Evidence: source-2026-07-29-017
Sources
- Children's Hospital Los Angeles via Newswise: GLP-1 use after adolescent sleeve gastrectomyChildren's Hospital Los Angeles via Newswise · secondary reporting
Corrections
No corrections have been recorded for this story.